awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28479103-1DFD8CFC-BFCD-473E-A9C6-C72692C22067
Q28479103-1DFD8CFC-BFCD-473E-A9C6-C72692C22067
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28479103-1DFD8CFC-BFCD-473E-A9C6-C72692C22067
Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection
P2860
Q28479103-1DFD8CFC-BFCD-473E-A9C6-C72692C22067
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28479103-1DFD8CFC-BFCD-473E-A9C6-C72692C22067
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a07e898dc463de12323c267a5d086e59fdd31de
P2860
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts